Update on the management of Candida infections in preterm neonates

P. Manzoni, M. Mostert, E. Castagnola

Research output: Contribution to journalArticlepeer-review


Invasive fungal infections in preterm neonates in the neonatal intensive care unit are predominantly caused by Candida spp, and have a high burden of morbidity and mortality. Effective prophylactic strategies have recently become available, but the identification of the best possible strategies to manage high-risk infants is still a priority. Choice and use of appropriate antifungal drugs needs careful assessment of neonatal characteristics, the epidemiology and drug pharmacokinetics. Ideally, antifungal drugs for preterm neonates should target fungal bio-films, prevent or effectively treat end-organ localisations, be active against fluconazole-resistant Candida species, and have reliable safety and tolerability profiles. The paper reviews the state-of-the-art in the area of neonatal fungal infections, and addresses some open questions related to the best possible prophylactic and therapeutic strategies to be implemented in such unique patients.

Original languageEnglish
Pages (from-to)F454-F459
JournalArchives of Disease in Childhood: Fetal and Neonatal Edition
Issue number5
Publication statusPublished - Sep 1 2015

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynaecology
  • Medicine(all)


Dive into the research topics of 'Update on the management of Candida infections in preterm neonates'. Together they form a unique fingerprint.

Cite this